Source: Eur Respir J, 56 (3) 2000626; 10.1183/13993003.00626-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Finn McQuaid, Katherine C. Horton, Anna S. Dean, Gwenan M. Knight, Richard G. White. The risk of multidrug- or rifampicin-resistance in males versus females with tuberculosis. Eur Respir J, 56 (3) 2000626; 10.1183/13993003.00626-2020

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcomes of extensively-drug resistant tuberculosis (XDR-TB) patients in 20 countries Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment Year: 2012 Characteristic of resistance of mycobacteria of tuberculosis to antibacterial preparations for acute progressing forms of tuberculosis of the lungs (APFTL) in females of fertile age Source: Eur Respir J 2006; 28: Suppl. 50, 12s Year: 2006 Increasing incidence of fluoroquinolone resistant tuberculosis in Bombay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 Drag resistant M. tuberculosis among tuberculosis patients in prisons Source: Eur Respir J 2001; 18: Suppl. 33, 313s Year: 2001 Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001 Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019 Year: 2020 Comorbidome in multidrug-resistant tuberculosis patients Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM) Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Poor infection control increase risk of reinfection with MDR or XDR-TB strains Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis Year: 2010 Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 A 34 year old male suspected to be a case of drug resistant tuberculosis Source: Case report 2015 Year: 2015 The burden of childhood and adult tuberculosis, including MDR and TDR TB Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Comparison of Nramp1 gene polymorphisms among tuberculosis healthy workers with positive PPD and recently infected cases; host susceptibility to tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019